A Deadline is coming up on September 26, 2017 in the lawsuit for investors in Foundation Medicine Inc (NASDAQ:FMI) and NASDAQ:FMI stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 09/28/2017 -- A deadline is coming up on September 26, 2017 in the lawsuit filed for investors of Foundation Medicine Inc (NASDAQ:FMI) over alleged securities laws violations by Foundation Medicine Inc.
Investors who purchased shares of Foundation Medicine Inc (NASDAQ:FM) have certain options and there are strict and short deadlines running. Deadline: September 26, 2017. NASDAQ:FMI stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
The plaintiff alleges on behalf of certain purchasers of Foundation Medicine Inc (NASDAQ:FMI), that the defendants made false and/or misleading statements regarding the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare and the Company's financial guidance.
Cambridge, MA based Foundation Medicine, Inc. is a molecular information company that sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies.
On July 29, 2015, Foundation Medicine Inc disclosed that "clinical volume growth was affected by slower than anticipated progress towards obtaining a local coverage determination from our regional Medicare Administrative Contractor (MAC) and by some competitive noise in the market" and that, as such, Foundation Medicine Inc was "adjusting" its guidance for clinical volume and annual revenues.
Then, on November 3, 2015, the Company disclosed a further revision to the already reduced number of clinical tests it expected to report for 2015.
Those who purchased shares of Foundation Medicine Inc (NASDAQ:FMI) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels